Skip to main content
Log in

Ocrelizumab

Neutropenia and off lable use

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Hess F, et al. Ocrelizumab-associated severe neutropenia: an underestimated complication of treatment of multiple sclerosis with anti-CD20 antibodies?. [German] Nervenarzt 94: 1153-1156, Dec 2023. Available from: URL: https://dx.doi.org/10.1007/s00115-023-01507-2 [German; summarised from a translation]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ocrelizumab. Reactions Weekly 2007, 281 (2024). https://doi.org/10.1007/s40278-024-58841-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-58841-8

Navigation